FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns a method for identifying the patients suffering myocardial infarction and a high risk of a cardiac pathology, involving a post-infarction examination of patient's biological fluids to measure vascular endothelium growth factor B (VEGFB), thrombospondin-1 (THBS1) and placental growth factor (PGF) levels. Besides, the group of inventions concerns a method for prediction for the patients suffering myocardial infarction; a system for identifying the suffering myocardial infarction.
EFFECT: group of inventions provides the reliable diagnosing of the high risk of the post-infarction cardiac pathology in the patients.
18 cl, 2 ex, 9 dwg, 7 tbl
